作者搜索结果 :: UTM Library Massive Scholar Tracking

1

The Forces Behind Cell Movement 由 Revathi Ananthakrishnan, Allen Ehrlicher

出版 2007-01-01

获取全文

文件
2

Pharmacological modeling and biostatistical analysis of a new drug 由 Revathi Ananthakrishnan, Philimon Gona

出版 2010-04-01

获取全文

文件
3

2D (2 Dimensional) TEQR design for Determining the optimal Dose for safety and efficacy 由 Revathi Ananthakrishnan, Stephanie Green, Daniel Li, Michael LaValley

出版 2019-12-01

获取全文

文件
4

An overview of the BOIN design and its current extensions for novel early-phase oncology trials 由 Revathi Ananthakrishnan, Ruitao Lin, Chunsheng He, Yanping Chen, Daniel Li, Michael LaValley

出版 2022-08-01

获取全文

文件
5

$Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma$

Phase 2 results of lisocabtagene maraleucel in Japanese patients with relapsed/refractory aggressive B‐cell non‐Hodgkin lymphoma 由 Shinichi Makita, Go Yamamoto, Dai Maruyama, Yuki Asano‐Mori, Daisuke Kaji, Revathi Ananthakrishnan, Ken Ogasawara, Lara Stepan, Claudia Schusterbauer, Nils Rettby, Jens Hasskarl, Koji Izutsu

出版 2022-12-01

获取全文

文件
6

$Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study$

Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study 由 Daniel J. DeAngelo, Wendy Stock, Anthony S. Stein, Andrei Shustov, Michaela Liedtke, Charles A. Schiffer, Erik Vandendries, Katherine Liau, Revathi Ananthakrishnan, Joseph Boni, A. Douglas Laird, Luke Fostvedt, Hagop M. Kantarjian, Anjali S. Advani

出版 2017-06-01

获取全文

文件